# MESALAMINE
> **ANDA220016** · Abbreviated New Drug Application (Generic) · Sponsor: KLM LABS PVT · Approved 2026-03-31
## Drug
- **FDA Application Number:** ANDA220016
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** ENEMA
- **Route:** RECTAL
- **Marketing status:** Prescription
- **Sponsor:** KLM LABS PVT
- **Manufacturer:** KLM Laboratories Private Limited
- **First approval:** 2026-03-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220016)
---
*AI Analytics · CC0 1.0*